Clare Arnott

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Michael Tsoukas

Assistant Professor of Medicine

McGill University Health Centre

CANADA

View details

Christine Jenkins

Head, Clinical Professor

University of Warwick University Bookshop

AUSTRALIA

View details

Rajiv Agarwal

Professor of Medicine

Indiana State University

UNITED STATES

View details

Gemma A Figtree

University of Sydney

AUSTRALIA

View details

Jochen Seufert

GERMANY

View details

Gian Luca Di Tanna

Visiting Professor

University of New South Wales

AUSTRALIA

View details

Patrick Rockenschaub

GERMANY

View details

Brendon Neuen

The George Institute for Global Health

AUSTRALIA

View details

Bruce Neal

University of New South Wales

AUSTRALIA

View details

george bakris

Professor of medicine, Director AHA Comprehensive Hypertension Center

University of Chicago

UNITED STATES

View details

Aletta Schutte

Professorial Fellow

The George Institute for Global Health

AUSTRALIA

View details

Adeera Levin

CANADA

View details

Lauren Houston

Conjoint Lecturer

University of New South Wales - Randwick Campus

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Clare Arnott

Research Interests

Explore related searches

Contact this professor

Articles (11)

The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

The effects of canagliflozin in type 2 diabetes in subgroups defined by population‐specific body mass index: Insights from the CANVAS Program and CREDENCE trial

Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials

Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE

Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial

Management of chronic breathlessness in primary care: what do GPs, non-GP specialists, and allied health professionals think?

Reassurance for parents with children bornvia assisted reproductive technology or too soon to tell?

Good for your heart and safe for your toes: a patient-level meta-analysis of DAPA-HF and DELIVER

The importance of targeting multiple risk markers in patients with type 2 diabetes: A post-hoc study from the CANVAS programme.

Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial

Collaborators (13)

Michael Tsoukas

Christine Jenkins

Rajiv Agarwal

Gemma A Figtree

Jochen Seufert

Gian Luca Di Tanna

Patrick Rockenschaub

Brendon Neuen

Bruce Neal

george bakris

Aletta Schutte

Adeera Levin

Lauren Houston

Make your next move.